BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24977668)

  • 1. FOXO1 downregulation contributes to the oncogenic program of primary mediastinal B-cell lymphoma.
    Xie L; Ritz O; Leithäuser F; Guan H; Färbinger J; Weitzer CD; Gehringer F; Bruederlein S; Holzmann K; Vogel MJ; Möller P; Wirth T; Ushmorov A
    Oncotarget; 2014 Jul; 5(14):5392-402. PubMed ID: 24977668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting.
    Romero M; Gapihan G; Castro-Vega LJ; Acevedo A; Wang L; Li ZW; El Bouchtaoui M; Di Benedetto M; Ratajczak P; Feugeas JP; Thieblemont C; Saavedra C; Janin A
    Oncotarget; 2017 Mar; 8(10):16243-16258. PubMed ID: 27806315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic mathematical modeling of IL13-induced signaling in Hodgkin and primary mediastinal B-cell lymphoma allows prediction of therapeutic targets.
    Raia V; Schilling M; Böhm M; Hahn B; Kowarsch A; Raue A; Sticht C; Bohl S; Saile M; Möller P; Gretz N; Timmer J; Theis F; Lehmann WD; Lichter P; Klingmüller U
    Cancer Res; 2011 Feb; 71(3):693-704. PubMed ID: 21127196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line.
    Melzner I; Bucur AJ; Brüderlein S; Dorsch K; Hasel C; Barth TF; Leithäuser F; Möller P
    Blood; 2005 Mar; 105(6):2535-42. PubMed ID: 15572583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of internal enhancer activity contributes to abnormally low immunoglobulin expression in the MedB-1 mediastinal B-cell lymphoma cell line.
    Ritz O; Leithäuser F; Hasel C; Brüderlein S; Ushmorov A; Möller P; Wirth T
    J Pathol; 2005 Feb; 205(3):336-48. PubMed ID: 15682441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma.
    Guiter C; Dusanter-Fourt I; Copie-Bergman C; Boulland ML; Le Gouvello S; Gaulard P; Leroy K; Castellano F
    Blood; 2004 Jul; 104(2):543-9. PubMed ID: 15044251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXO1 is a tumor suppressor in classical Hodgkin lymphoma.
    Xie L; Ushmorov A; Leithäuser F; Guan H; Steidl C; Färbinger J; Pelzer C; Vogel MJ; Maier HJ; Gascoyne RD; Möller P; Wirth T
    Blood; 2012 Apr; 119(15):3503-11. PubMed ID: 22343918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A first-in-class inhibitor of HSP110 to potentiate XPO1-targeted therapy in primary mediastinal B-cell lymphoma and classical Hodgkin lymphoma.
    Durand M; Cabaud Gibouin V; Duplomb L; Salmi L; Caillot M; Sola B; Camus V; Jardin F; Garrido C; Jego G
    J Exp Clin Cancer Res; 2024 May; 43(1):148. PubMed ID: 38773631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Landscape of Primary Mediastinal B-Cell Lymphoma Cell Lines.
    Dai H; Ehrentraut S; Nagel S; Eberth S; Pommerenke C; Dirks WG; Geffers R; Kalavalapalli S; Kaufmann M; Meyer C; Faehnrich S; Chen S; Drexler HG; MacLeod RA
    PLoS One; 2015; 10(11):e0139663. PubMed ID: 26599546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT6-mediated BCL6 repression in primary mediastinal B-cell lymphoma (PMBL).
    Ritz O; Rommel K; Dorsch K; Kelsch E; Melzner J; Buck M; Leroy K; Papadopoulou V; Wagner S; Marienfeld R; Brüderlein S; Lennerz JK; Möller P
    Oncotarget; 2013 Jul; 4(7):1093-102. PubMed ID: 23852366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Expression Profiling of Mediastinal Gray Zone Lymphoma and Its Relationship to Primary Mediastinal B-cell Lymphoma and Classical Hodgkin Lymphoma.
    Pittaluga S; Nicolae A; Wright GW; Melani C; Roschewski M; Steinberg S; Huang D; Staudt LM; Jaffe ES; Wilson WH
    Blood Cancer Discov; 2020 Sep; 1(2):155-161. PubMed ID: 32914098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in MedB-1 mediastinal lymphoma line].
    Barth TF; Melzner I; Wegener S; Bucur AJ; Brüderlein S; Dorsch K; Hasel C; Leithäuser F; Möller P
    Verh Dtsch Ges Pathol; 2005; 89():234-44. PubMed ID: 18035697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant hematopoietic cell lines: in vitro models for the study of primary mediastinal B-cell lymphomas.
    Drexler HG; Ehrentraut S; Nagel S; Eberth S; MacLeod RA
    Leuk Res; 2015 Jan; 39(1):18-29. PubMed ID: 25480038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphoma.
    Vogel MJ; Xie L; Guan H; Tooze RM; Maier T; Kostezka U; Maier HJ; Holzmann K; Chan FC; Steidl C; Reichel JB; Weitzer CD; Gehringer F; Kick AB; Cesarman E; Roshal M; Gascoyne RD; Möller P; Wirth T; Ushmorov A
    Blood; 2014 Nov; 124(20):3118-29. PubMed ID: 25232062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma.
    Jardin F; Pujals A; Pelletier L; Bohers E; Camus V; Mareschal S; Dubois S; Sola B; Ochmann M; Lemonnier F; Viailly PJ; Bertrand P; Maingonnat C; Traverse-Glehen A; Gaulard P; Damotte D; Delarue R; Haioun C; Argueta C; Landesman Y; Salles G; Jais JP; Figeac M; Copie-Bergman C; Molina TJ; Picquenot JM; Cornic M; Fest T; Milpied N; Lemasle E; Stamatoullas A; Moeller P; Dyer MJ; Sundstrom C; Bastard C; Tilly H; Leroy K
    Am J Hematol; 2016 Sep; 91(9):923-30. PubMed ID: 27312795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gains of REL in primary mediastinal B-cell lymphoma coincide with nuclear accumulation of REL protein.
    Weniger MA; Gesk S; Ehrlich S; Martin-Subero JI; Dyer MJ; Siebert R; Möller P; Barth TF
    Genes Chromosomes Cancer; 2007 Apr; 46(4):406-15. PubMed ID: 17243160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma.
    Ritz O; Guiter C; Castellano F; Dorsch K; Melzner J; Jais JP; Dubois G; Gaulard P; Möller P; Leroy K
    Blood; 2009 Aug; 114(6):1236-42. PubMed ID: 19423726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas.
    Malpeli G; Barbi S; Moore PS; Scardoni M; Chilosi M; Scarpa A; Menestrina F
    Haematologica; 2004 Sep; 89(9):1091-9. PubMed ID: 15377470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isotype-switched immunoglobulin genes with a high load of somatic hypermutation and lack of ongoing mutational activity are prevalent in mediastinal B-cell lymphoma.
    Leithäuser F; Bäuerle M; Huynh MQ; Möller P
    Blood; 2001 Nov; 98(9):2762-70. PubMed ID: 11675349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biallelic deletion within 16p13.13 including SOCS-1 in Karpas1106P mediastinal B-cell lymphoma line is associated with delayed degradation of JAK2 protein.
    Melzner I; Weniger MA; Bucur AJ; Brüderlein S; Dorsch K; Hasel C; Leithäuser F; Ritz O; Dyer MJ; Barth TF; Möller P
    Int J Cancer; 2006 Apr; 118(8):1941-4. PubMed ID: 16287070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.